|Articles|January 1, 2008
Two-hour MRSA blood test approved
Advertisement
FDA News
On January 2, the Food and Drug Administration (FDA) approved a two-hour staph blood test, which can detect 100% of dangerous specimens and 98% of more commonplace bacteria.
The test, Becton Dickinson's BD GeneOhm StaphSR Assay, is designed to test for methicillin-resistant Staphylococcus aureus (MRSA). Previous tests could take days to deliver results. BD has also submitted paperwork for tests based on nasal swabs and wound claims.
The panel tests for 12 viruses and viral subtypes, including influenza A, human metapneumovirus, and adenovirus. The test is currently available.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Early antiviral therapy linked to 81% lower influenza hospitalization risk in children
2
Dawn Dore-Stites, PhD, explains how permanent daylight saving time could affect children
3
Permanent Daylight Saving Time could disrupt sleep and school performance in children, expert says
4
Gut microbe metabolite may aid malnutrition-related gut damage
5